Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Macrolide Pharmaceuticals

Macrolide Pharmaceuticals
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$20M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of novel antibiotic compounds created to improve the lives of patients suffering from serious infections. The company's fifth-generation macrolide antibiotics harnesses the power of synthetic chemistry and microbiology used in the treatment of serious, multi-drug resistant gram-negative infections, enabling patients to recover quickly from multiple infection conditions.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 480 Arsenal Way
  • Suite 130
  • Watertown, MA 02472
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Macrolide Pharmaceuticals’s full profile, request a free trial.

Macrolide Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 02-Apr-2018 $20M 000.00 000.00 Completed Pre-Clinical Trials
3. Grant 26-Mar-2018 00.00 000.00 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 25-Feb-2015 $22.3M $22.3M 000.00 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Macrolide Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Macrolide Pharmaceuticals Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tetraphase Pharmaceuticals Formerly VC-backed Watertown, MA 000 00000 00000000000 00000
00000 000000000000 Venture Capital-Backed San Diego, CA 000.00 0000000000 000.00
00000000 Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
00000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
00000000 Formerly VC-backed Allschwil, Switzerland 000 00000 000000000 00000
To view this company’s complete list of competitors, request access »

Macrolide Pharmaceuticals Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CARB-X Government 000 0000 000000 0
Advent Life Sciences Venture Capital Minority 000 0000 000000 0
Gurnet Point Capital PE/Buyout Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Roche Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Macrolide Pharmaceuticals Executive Team (11)

Name Title Board
Seat
Contact
Info
Sumit Aggarwal Board Member, President and Chief Executive Officer
Thomas McCauley Chief Scientific Officer
Yoshitaka Ichikawa Ph.D Vice President
Joseph Zakrzewski Chairman
Vikas Goyal Director

6 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

Macrolide Pharmaceuticals Board Members (14)

Name Representing Role Since Contact
Info
Andrew Myers Ph.D Macrolide Pharmaceuticals Co-Founder, Board of Scientific Advisor & Board Member 000 0000
Anja Harmeier Ph.D Roche Venture Fund Board Member 000 0000
Christopher Viehbacher Gurnet Point Capital Board Member 000 0000
Henry Skinner Ph.D Novartis Venture Fund Chairman 000 0000
Joseph Zakrzewski Macrolide Pharmaceuticals Chairman 000 0000

3 Former Board Members

You’re viewing 5 of 14 board members. Get the full list »